We have constructed a series of deletion mutants spanning the genome of duck hepatitis B virus in order to determine which regions of the viral genome are required in cis for packaging of the pregenome into capsid particles. Deletion of sequences within either of two nonadjacent regions prevented replication of the mutant viral genomes expressed in a permissive avian hepatoma cell line in the presence of functionally active viral core and P proteins. Extraction of RNA from cells transfected with these replication-defective mutants showed that the mutahts retained the capacity to be transcribed into a pregenomic-size viral RNA, but that these RNA species were not packaged into viral capsids. The two regions defined by these deletions are located 36 to 126 (region I) and 1046 to 1214 (region II) nucleotides downstream of the 5' end of the pregenome and contain sequences which are required in cis for encapsidation of the duck hepatitis B virus pregenome.
The hepadnaviruses are a family of small, enveloped DNA viruses that replicate through reverse transcription of an RNA intermediate (20) . During productive infection by the virus, three major species of viral RNA transcripts are produced. Of these RNA transcripts, only the terminally redundant viral pregenomic RNA is packaged into nucleocapsids (7), indicating that the selection for encapsidation is a highly specific process. Assembly of viral components to produce a replication-competent viral particle also requires inclusion of the viral reverse transcriptase, known as the P protein, which may also play a structural role in the nucleocapsid.
It is known that a single cis-acting sequence is sufficient for packaging of the human hepatitis B virus (HBV) pregenome into viral core particles (12) . Previously published work has suggested that the avian hepatitis B viruses may require a more complex signal (10) . We have constructed and tested a series of 38 deletion mutants in duck hepatitis B virus (DHBV) in order to localize the elements of RNA required in cis for encapsidation of the avian pregenome. Our results show that unlike the case for HBV, the DHBV pregenome contains two regions which are required in cis for encapsidation of the pregenome into nucleocapsids. The requirement for these two regions for encapsidation explains the previous result of Hirsch et al. (10) , who showed that the 5' third of the DHBV pregenome contained sequences that were necessary and sufficient for packaging of a heterologous RNA into viral capsids.
MATERIALS AND METHODS
Plasmids and mutations. Two libraries of random deletion mutants were derived from a plasmid, pSPDHBV Gal5.1(2X), which contained two head-to-tail copies of DHBV DNA (17) . Random double-stranded cleavages were introduced by digestion with limiting concentrations of DNase I in the presence of Mn2 . In one library, Sacd linkers (CGAGCTCG) were ligated to the digested ends after blunting with the large (Klenow) fragment of DNA polymerase I, while in a second library, ClaI linkers (CCATCGATGG) were ligated to ends after brief * (6) to create a series of pUCl19.CMV.DHBV deletion mutants.
Additional deletion mutants were constructed by digesting an overlength DHBV containing plasmid, pUC119.CMV. DHBV, with specific restriction enzymes. Free ends resulting from such digestions were incubated with E. coli DNA polymerase I Klenow fragment in the presence of all four deoxynucleoside triphosphates and subsequently religated after removal of the intervening sequences. The sizes and locations of deleted regions in mutants which were found to be replication defective were confirmed by the dideoxy-chain termination technique, using Sequenase version 2.0 (U.S. Biochemical Corp.). All nucleotide numbering is that established by Mandart et The lysate was centrifuged to sediment nuclei and cell debris. The supernatant was treated as previously described (21) . Briefly, supernatant was treated with DNase I to remove transfected DNA and then incubated with protease and sodium dodecyl sulfate to release nucleic acids contained within the nucleocapsid particles. After extraction with phenol, nucleic acids were precipitated with ethanol. Typically, 1/10 of each cell lysate was electrophoresed through a 1% agarose gel, transferred to a nylon membrane, and hybridized with a 32P-labeled RNA specific for detection of minus-stranded nucleic acids.
Analysis of viral RNA. Total viral RNA was isolated from transfected cells 3 days after transfection, using the guanidinium method as described previously (1) . Briefly, cells transfected with wild-type or mutant DNA plasmids were lysed in 4 M guanidinium thiocyanate solution acidified with 50 mM sodium acetate (pH 4.0). The RNA from the cell lysates was pelleted in 5.7 M cesium chloride, precipitated with ethanol, then redissolved in 0.01 M sodium phosphate (pH 7.5), and treated with glyoxal for 1 h at 50°C. One-fiftieth of the prepared cell lysate was electrophoresed through a I % agarose gel containing 2 mg of sodium iodoacetate per ml (18) , transferred to nylon filters, and hybridized with a 32P-labeled RNA specific for detection of viral plus-stranded nucleic acids.
Assay for nucleocapsid particles. Transfected cells were rinsed once with HEPES-buffered saline 3 days posttransfection and then lysed with 0.5 ml of lysis buffer (10 mM Tris-HCl [pH 7.5], 1 mM EDTA, 1% Nonidet P-40) per 60-mmdiameter plate for 10 min at 37°C. The lysate was centrifuged for 1 min in a microcentrifuge to remove nuclei and cell debris. The supernatant was adjusted to contain 6 ,uM magnesium acetate and 100,ug of DNase I per ml and incubated for 30 min at 37°C. The cell lysates were centrifuged again, and 10 [I1 of the resulting supernatant (1/50 of the cell lysate) was electrophoresed through a 1% agarose gel in 10 mM sodium phosphate buffer (pH 7.5) with constant circulation of the electrode buffer. Core particles were transferred to nitrocellulose filters through capillary action in TNE (10 mM Tris-HCl, 150 mM NaCl, 1 mM EDTA) overnight. Filters were rinsed briefly in deionized water and then air dried under a heat lamp. Capsids were detected by immunostaining the filters with rabbit anticore antibody prepared against DHBV cores produced in bacteria (gift of Ray Lenhoff) followed by binding with 1251_ labeled protein A.
Indirect immunofluorescence was performed on transfected cells 2 days posttransfection. Cells were rinsed once with HEPES-buffered saline and fixed overnight in 95% ethanol-5% acetic acid. Core protein was detected by incubation with rabbit anti-core antibody and was visualized with rhodamine-conjugated goat anti-rabbit antibody.
Assay for encapsidation of viral RNA. Transfected cells were treated as described for the analysis of nucleocapsid particles except that capillary transfer of the intact particles was to nylon filters. After transfer, the filters were air dried. Encapsidated nucleic acids were released from the core particles in situ by wetting the filter for 15 s in 0.2 N NaOH-1.5 M NaCl. The treated filters were then neutralized for 15 s in 0.2 N Tris-HCI-1.5 M NaCl, rinsed briefly in deionized water, fixed to the filter with UV light, and again air dried. The treated filters were hybridized with a 329P-labeled RNA specific for detection of viral plus-stranded nucleic acids.
RESULTS
All regions of the hepadnaviral genome encode at least one viral protein. Therefore, deletion of any sequences within the genome can interrupt the coding regions of proteins which are required for viral replication. To study the effects of deletions upon packaging of the pregenome into nucleocapsids, it was necessary to complement deletion mutants with plasmids which could supply necessary proteins in trans. Previous encapsidation experiments of Hirsch et al. (10) demonstrated that sequences located within a region which began approximately 35 nucleotides downstream of the pregenomic cap site were required for encapsidation in DHBV. Our initial experiments confirmed these results and demonstrated that a DHBV mutant lacking the first 43 nucleotides of the pregenome-encoding sequences (2569Cap) produced a pregenome which could be translated to produce core and P protein but which was not packaged. We chose this terminal deletion mutant to complement core-and/or P-defective deletion mutants, since it could not generate a pregenomic RNA which would complete for packaging with the test mutants during subsequent transfection analyses.
Hepadnaviral nucleocapsids are composed of multiple core protein monomers. It has been shown that mutations within the core open reading frame have the potential for producing defective proteins which may interfere in trans with nucleocapsid particle assembly (1 1). To prevent dominant negative effects of defective core proteins, a mutation was introduced immediately downstream of the translation initiation codon of the core open reading frame at nucleotide 2651 in all of the deletion mutants. This mutation produced a 2-bp frameshift which shifted the core open reading frame to one which contained a nonsense codon at nucleotide 2664, so that translation of defective core protein monomers was prevented. Three regions of the DHBV genome are required in cis for viral replication. To determine which regions of the DHBV pregenome are required for encapsidation, we tested 38 deletion mutants for the ability to synthesize viral DNA when P and core proteins were supplied in trans. If all elements required for the encapsidation process and for DNA synthesis were present, DNA synthesis would occur within the nucleocapsid particle. However, if one or more required elements were absent, no DNA replicative intermediates would be produced.
Individual deletion mutants (Fig. 1B) were cotransfected into the permissive cell line LMH, along with helper plasmid 2569Cap to supply viral proteins in trans, and assayed for the ability to synthesize viral DNA. As shown in Fig. 2 These results revealed that deletion of sequences within three discontinuous regions of the genome prevented synthesis of viral DNA.
All mutants which were found to be replication defective accumulated pregenomic RNA species which migrated as expected (Fig. 3) . Thus, the inability of these deletion mutants to synthesize DNA intermediates was not due to an inability to transcribe pregenomic RNA templates from the transfected mutant plasmids. We also tested each of the complemented deletion mutants to determine whether nucleocapsid particles were formed from the core protein supplied by the helper plasmid during the cotransfections. As shown in Fig. 4A which define region II are located approximately 380 nucleotides downstream of the putative initiation site for P protein translation at nucleotide 170. If translation of P protein was initiated from the deletion mutant plasmids, a defective P protein could be synthesized which might interfere with the complementation of the P protein supplied in trans. To determine whether such a defective P protein was responsible for the packaging defect of region II mutants, we deleted nucleotides 1 to 391 upstream of a region II deletion mutant (563-678), effectively removing the first three potential initia- tion codons of the P open reading frame. If the inability to encapsidate the mutant pregenome was due to the presence of an interfering P protein generated from the region II mutant, we expected that by preventing any translation of the P protein from this double mutant, we could restore the packaging capacity of the defective region. As shown in Fig. 5 , preventing expression of P protein from the region II mutant did not restore the packaging capacity of the region II mutant.
Mutant pregenomes are present in the cytoplasm of transfected cells. It was possible that a packaging defect could be due to an inability of the pregenome to reach the cytoplasm and interact with the encapsidation machinery. To determine whether the mutant pregenomic RNA was present in the cytoplasm of the transfected cells, we examined cells individually transfected with 2569Cap and a core-positive region II deletion mutant (563-678) for the presence of core protein in the cytoplasm. As shown in Fig. 6 , both region I and region II deletion mutants produced detectable core protein, indicating that the mutant pregenome, which also serves as mRNA for core protein, was accessible to translational machinery in the cytoplasm of the transfected cells.
DISCUSSION
Our results demonstrate that in contrast to the single s encapsidation signal required for packaging of the HBV pregenome (12) , two discontinuous regions of the DHBV pregenome are required in cis for encapsidation of pregenomic RNA into nucleocapsids. Our data confirm and extend the results of Hirsch et al. (10) (3, 14) .
Although several reports have shown that the P protein is required for encapsidation in both HBV and DHBV, it appears that encapsidation does not depend on the DNA polymerase activity of the P protein (2, 5, 9) . We and others have previously shown that nucleocapsid assembly can be achieved independent of the P protein (4, 15a, 19) . The results reported demonstrated that assembly of core particles proceeds in the absence of a packaging competent RNA pregenome. Our results are consistent with a model of encapsidation proposed by Bartenschlager and Schaller (3) in which the P protein is required for the selection of pregenomic RNA for encapsidation through interaction with sequences contained within region I, but our results suggest that assembly of viral core proteins into capsids occurs independent of the P protein, while encapsidation of viral RNA is a P protein-dependent process.
The second encapsidation signal, region II (nucleotides 551 to 719), contains sequences which are also required for efficient encapsidation of the DHBV pregenome, but the role of this region in packaging is unclear. The sequences contained within region II do not share significant sequence homology or predicted secondary structure with those sequences within region I. The packaging function of region II mutants was not restored when P protein translation was prevented from the mutant template, indicating that the defect observed for region II deletion mutants was not due to interference by truncated P proteins.
Deletion analysis of the HBV genome (12) showed that deletions of sequences analogous to region II of DHBV did not affect packaging of the pregenome into nucleocapsids when P protein was supplied in trans. This divergence in the mechanism of encapsidation between the human and avian hepatitis B viruses is surprising, as within the family of hepadnaviruses, a high degree of similarity in structure and replication strategy is retained despite divergent species specificity.
The deletion of sequences between 2350 and 2560 (region III) did not significantly affect the level of pregenomic packaging, indicating that sequences within this region were not essential for encapsidation. This region does, however, contain two 11-bp repeats, DR1 and DR2, which are involved in the initial stages of viral minus-and plus-strand DNA synthesis. The Finally, region II may not be involved in the encapsidation process per se but rather may be involved in a step which is required prior to encapsidation. It is known that the viral pregenome has a dual role during the hepadnavirus replication cycle, serving both as a message for both P and core protein translation and as the genomic element which is encapsidated. Region II may contain elements required to allow a transition of the pregenome from its role as an mRNA to a substrate for encapsidation.
